GEICAM2003_2A: GEICAM2003, figure 2A

GEICAM2003_2AR Documentation

GEICAM2003, figure 2A

Description

Kaplan-Meier digitized data from GEICAM2003, figure 2A (PMID 26416999). A reported sample size of 1,384 for a primary endpoint of iDFS in breast cancer.

Usage

GEICAM2003_2A

Format

A data frame of 1,384 observations and 3 variables:

time event time (in years)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (ec_t, et_x)

Source

Martín M, Ruiz Simón A, Ruiz Borrego M, et al. Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study. J Clin Oncol 2015; 33: 3788–95.

Examples

summary(GEICAM2003_2A)

kmplot(GEICAM2003_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.